DROXIDOPA (has an active metabolite) | DROXIDOPA | ATC C01CA27
CARDIOVASCULAR TREATMENT OF ORTHOSTATIC DIZZINESS AND LIGHTHEADEDNESS SYNTHETIC AMINO ACID PRECURSOR OF NOREPINEPHRINE SUBSTRATE OF DOPA-DECARBOXYLASE | ORAL | Tmax 2 HOUR VD 200 LITER PPB 75 PERCENT Cl 55.4 LITER / HOUR (EQN) HT 2.5 HOUR SOLUBILITY SLIGHTLY SOLUBLE IN WATER | DOPA-DECARBOXYLASE | ADRENERGIC RECEPTOR AGONIST CHEMBL2331074 ADRENERGIC RECEPTOR P07550 BETA-2 ADRENERGIC RECEPTOR HOMO SAPIENS MEMBRANE RECEPTOR 7TM1 SMALLMOL MONOAMINE RECEPTOR ADRENERGIC RECEPTOR | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |